CW November 2001

category image Volume 10
Issue Number 11
November 2001
ISSN 10593802

To Shift Immune Response in Favor of Anti-Tumor Immunity

Introduction, in animal model, of engineered T-cells that block transforming growth factor?beta action can significantly improve anti-tumor immunity. This strategy can be used alone or as an adjunct to other immunomodulating therapy in certain cancer patients.
Go to Previous Page
Go to Next Page

Source & Additional Reading

L. Gorelik and R. Flavell, Nature Medicine, October 2001.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW November 2001

Purchase Downloadable Full-text PDF of Complete Issue: $10.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login